 
        
        
         
                                 
                                
                            

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + | 
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
 
                        
                    
| 产品名称 | Opioid receptor ↓ ↑ | ORL1 ↓ ↑ | μ-opioid receptor ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Racecadotril | ✔ | 98% | |||||||||||||||||
| JTC-801 | ++ Opioid receptor-like1 (ORL1), IC50: 94 nM | 98% | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 描述 | Nociceptin, a heptadecapeptide, is the endogenous ligand of the nociceptin receptor, acting as a potent anti-analgesic. Nociceptin (1 μg/mL) significantly prevents LPS (10 ng/mL)-stimulated cell migration whereas it is ineffective when added alone. Nociceptin (1 nM-10 μM) elicits a concentration-dependent blockade of LPS-mediated cell migration, with a maximal effect at 1 and 10 μM. Nociceptin counteracts LPS-induced elevation of IL-1β mRNA levels. Nociceptin (1 μM) and NNC 55-0396 induce apoptotic cell death in U87 cells. Nociceptin (1 μM) counteracts LPS-induced [Ca2+]i increase in U87 cells via β-arrestin 2. Nociceptin counteracts the LPS-induced phosphorylation of PKC and ERK in U87 cells. Nociceptin inhibits the LPS-mediated transcriptional activation of NF-kB and AP-1 reporter genes[1]. The i.v. administration of nociceptin (10-100 nmol/kg) inhibits the micturition reflex in a naloxone-resistant manner. Intrathecal nociceptin (10 nmol/rat) produces urodynamic modifications similar to those induced by the i.v. administration. Intracerebroventricular (i.c.v.) administration of nociceptin (0.3-1 nmol/rat) also inhibited the micturition reflex in a naloxone-resistant manner suggesting a direct effect on supraspinal sites controlling the micturition. The application of nociceptin (5-50 nmol/rat) onto the bladder serosa when the intravesical volume was subthreshold for the triggering of the micturition reflex, activated the reflex in a dose-dependent manner; the same treatment produced a biphasic effect on the ongoing reflex[2]. Injection of nociceptin into mice stimulated Rec8 phosphorylation and meiotic chromosome dynamics in testes, whereas injection of nocistatin, a specific inhibitor for nociceptin, abolished them[3]. | 
| Concentration | Treated Time | Description | References | |
| Neurons in CeA slices | 500 nM | 10 minutes | To investigate the effect of Nociceptin on GABAergic transmission in CeA neurons, results showed that Nociceptin significantly decreased sIPSC frequency in oxycodone-dependent HA rats but had less effect on LA and naive rats. | Proc Natl Acad Sci U S A. 2020 Jan 28;117(4):2140-2148 | 
| Administration | Dosage | Frequency | Description | References | ||
| Rats | Rats with high (HA) and low (LA) addiction-like behaviors | Bilateral CeA injections | 1 μg/0.5 μL/site | Single injection | To investigate the effect of Nociceptin on oxycodone self-administration, results showed that Nociceptin selectively reduced oxycodone intake in HA rats but was ineffective in LA rats. | Proc Natl Acad Sci U S A. 2020 Jan 28;117(4):2140-2148 | 
| Guinea-pigs | Capsaicin-induced cough model | Intracerebroventricular (i.c.v.) and intravenous (i.v.) | 10, 30, 90 μg (i.c.v.); 0.3, 1.0, 3.0 mg/kg (i.v.) | Single dose, 15 minutes before capsaicin challenge | To evaluate the inhibitory effect of Nociceptin on capsaicin-induced cough. Results showed that both i.c.v. and i.v. administration dose-dependently inhibited cough, and the effect of i.c.v. administration (90 μg) was blocked by ORL1 receptor antagonists but not affected by the opioid receptor antagonist naltrexone. | Br J Pharmacol. 2001 Mar;132(6):1175-8 | 
| Guinea pigs | HCl-induced airway microvascular leakage model | Intravenous injection | 3–30 μg/kg | Single dose, administered 1 min before Evans blue dye | To investigate the inhibitory effect of Nociceptin on HCl-induced airway microvascular leakage, showing that Nociceptin inhibited leakage in a dose-dependent manner, with maximal inhibition at 30 μg/kg. | Br J Pharmacol. 2004 Mar;141(6):1077-83 | 
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 | 
| NCT03193398 | Major Depressive Disorder | Phase 2 | Active, not recruiting | December 2018 | United States, California ... 展开 >> United States Cerritos, California, United States, 90703 United States Garden Grove, California, United States, 92845 United States, Florida United States, Florida Jacksonville, Florida, United States, 32256 United States Lauderhill, Florida, United States, 33319 United States, Florida Orlando, Florida, United States, 32801 United States, Illinois United States Libertyville, Illinois, United States, 60048 United States, New York United States Rochester, New York, United States, 14618 United States, Tennessee United States Memphis, Tennessee, United States, 38119 收起 << | 
| NCT03302416 | Healthy | Early Phase 1 | Recruiting | June 1, 2019 | United States, Pennsylvania ... 展开 >> University of Pittsburgh Recruiting Pittsburgh, Pennsylvania, United States, 15213 收起 << | 
| NCT00173225 | - | Unknown | - | Taiwan ... 展开 >> Ping-Hung Kuo Recruiting Taipei, Taiwan, 100 Contact: Ping-Hung Kuo, MD 886-2-23123456 ext 3075 kph@ntumc.org Principal Investigator: Ping-Hung Kuo, MD 收起 << | |
| 计算器 | ||||
| 存储液制备 |  | 1mg | 5mg | 10mg | 
| 1 mM 5 mM 10 mM | 0.55mL 0.11mL 0.06mL | 2.76mL 0.55mL 0.28mL | 5.53mL 1.11mL 0.55mL | |
| CAS号 | 170713-75-4 | 
| 分子式 | C79H129N27O22 | 
| 分子量 | 1809.04 | 
| SMILES Code | NC(CC[C@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC(CNC([C@@H](NC([C@H](CC1=CC=CC=C1)NC(CNC(CNC([C@H](CC2=CC=CC=C2)N)=O)=O)=O)=O)[C@@H](C)O)=O)=O)C)=O)CCCNC(N)=N)=O)CCCCN)=O)CO)=O)C)=O)CCCNC(N)=N)=O)CCCCN)=O)CC(C)C)=O)C)=O)CC(N)=O)=O)C(O)=O)=O | 
| MDL No. | MFCD05861378 | 
| 别名 | Orphanin FQ | 
| 运输 | 蓝冰 | 
| InChI Key | PULGYDLMFSFVBL-SMFNREODSA-N | 
| Pubchem ID | 16131448 | 
| 存储条件 | In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, inert atmosphere, store in freezer, under -20°C | 
| 溶解方案 | DMSO: 50 mg/mL(27.64 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO H2O: 50 mg/mL(27.64 mM) 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶 
 
 
 
 | 
 沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1
			沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1